| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 08/07/2003 | WO2003063797A2 Cycloalkyl inhibitors of potassium channel function |
| 08/07/2003 | WO2003030886A3 Allylamides useful in the treatment of alzheimer's disease |
| 08/07/2003 | US20030149060 A2A adenosine receptor antagonists |
| 08/07/2003 | US20030149052 Side effect reduction |
| 08/07/2003 | US20030149038 Alpha-helix mimicry by a class of organic molecules |
| 08/07/2003 | US20030149037 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc. |
| 08/07/2003 | CA2474451A1 Cycloalkyl inhibitors of potassium channel function |
| 08/06/2003 | EP1332132A2 Enamine derivatives as cell adhesion molecules |
| 08/06/2003 | EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 08/06/2003 | EP1140853B1 Continuous process for the preparation of optically pure decahydroisoquinolinecarboxamide |
| 08/06/2003 | CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives |
| 08/06/2003 | CN1434819A 4-phenyl-peiperazinyl,-piperidinyl and -Tetrahydropyridyl derivatives |
| 08/06/2003 | CN1117079C Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine |
| 08/05/2003 | CA2077708C Cyclic nitrones |
| 07/31/2003 | WO2003063555A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 07/31/2003 | WO2003062261A2 Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use |
| 07/31/2003 | WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
| 07/31/2003 | WO2003061660A1 Melanocortin receptor agonists |
| 07/31/2003 | WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai |
| 07/31/2003 | US20030144507 Sulfonamide-containing heterocyclic compounds |
| 07/31/2003 | US20030144487 Directed to luminescent lanthanide compounds with phosphine oxide, phosphine oxide- sulfide, pyridine N-oxide, and phosphine oxide-pyridine N-oxide ligands. It also relates to electronic devices in which the active layer includes a |
| 07/31/2003 | US20030144320 For treatment and/or prevention of anxiety, mania, depression, panic disorders, nerve sustem disorders |
| 07/31/2003 | US20030144319 2-Substituted piperidine analogs as excitatory amino acid receptor antagonists that block N-methyl-D-aspartic acid receptors; neuroprotective agents; stroke; brain disorders; antiischemic agents; anxiolytic agents; headaches; analgesics |
| 07/31/2003 | US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 07/31/2003 | US20030144137 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 07/31/2003 | US20030143481 Image forming material and ammonium compound |
| 07/31/2003 | CA2473036A1 Melanocortin receptor agonists |
| 07/31/2003 | CA2455844A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 07/30/2003 | EP1330439A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 07/30/2003 | EP0705100B1 Therapeutic substituted guanidines |
| 07/30/2003 | CN1116284C Process for preparation of alpha, alpha'-diaminoalcohol |
| 07/29/2003 | CA2266357C Pictet-spengler reaction for the synthesis of tetrahydroisoquinolines and related heterocyclic compounds |
| 07/24/2003 | WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 07/24/2003 | WO2003024934A3 Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases |
| 07/24/2003 | US20030139449 Anxiolytic agents; psychological disorders; cognition activators |
| 07/24/2003 | CA2471562A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 07/23/2003 | EP0888278B1 Antidiabetic agents |
| 07/23/2003 | CN1431199A Method for synthesizing 1-amino isoquinoline |
| 07/23/2003 | CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 07/22/2003 | US6596903 Ring opening 4-(2-amino-1-hydroxyethyl)oxazoline by reaction with organic mercaptan; stereospecific; human immunodeficiency virus protease inhibitors |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/22/2003 | US6596734 Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057254A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | US20030135051 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors |
| 07/17/2003 | US20030135049 Preparing camptothecin intermediates |
| 07/17/2003 | US20030135045 Glycoprotein IIb/IIIa antagonists |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/17/2003 | CA2471760A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/16/2003 | EP1326824A1 Pharmaceutical compounds |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1430605A Process for synthesis of amine ethers from secondary amino oxides |
| 07/16/2003 | CN1430602A Ary-and heteroaryl sulfonates compounds |
| 07/15/2003 | US6593341 β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same |
| 07/15/2003 | US6593322 Compounds and methods for modulation of estrogen receptors |
| 07/15/2003 | CA2286013C Process for making a butylthio-isoquinoline and intermediates therefor |
| 07/10/2003 | WO2003055880A2 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 07/10/2003 | WO2003055848A2 Urea derivatives as vr1- antagonists |
| 07/10/2003 | WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 07/10/2003 | US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion |
| 07/10/2003 | US20030130342 Such as anticoagulant 3-(6-(4-(aminoiminomethyl)phenyl methoxy)-2-methyl-2H-1-benzopyran-2-yl)propanoic acid hydrochloride |
| 07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
| 07/10/2003 | US20030130270 Heterocyclic derivatives and their use as antithrombotic agents |
| 07/10/2003 | CA2471217A1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 07/10/2003 | CA2469967A1 Urea derivatives as vr1- antagonists |
| 07/09/2003 | EP1325915A1 Monomeric and dimeric naphtylisoquinoline alkaloids and synthesis methods thereof |
| 07/09/2003 | EP1325912A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |
| 07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
| 07/09/2003 | CN1113872C Tricyclicbenzo [e] isoindole and benzo [h] isoquinoline |
| 07/09/2003 | CN1113870C Preparation of butylthio-isoquinoline and intermediate thereof |
| 07/09/2003 | CN1113869C Two aporphine-benzyl isoquinoline compounds with antitumour activity |
| 07/08/2003 | US6589963 Drug salt thereof show a hypoglycemic action, a blood hypolipidemic action, an insulin resistance-improving action and a PPAR activating action, and are useful as a hypoglycemic agent, a hypolipidemic agent, an insulin |
| 07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
| 07/03/2003 | WO2003053330A2 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3 |
| 07/03/2003 | WO2002101073A3 Aryl-benzimidazole compounds having antiinfective activity |
| 07/03/2003 | US20030125304 Substituted amino ketone compounds |
| 07/02/2003 | EP1323711A1 Novel phenylalanine derivatives |
| 07/02/2003 | EP1323160A1 Optical data carrier containing a phthalocyanine colouring agent as a light absorbing compound in the information layer |
| 07/02/2003 | EP1322906A1 Optical data storage device containing a co-phthalocyanin complex in the optically writable information layer |
| 07/02/2003 | EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai |
| 07/02/2003 | EP1322619A1 Isoquinolinone potassium channel inhibitors |
| 07/02/2003 | EP1322618A1 Amino heterocyclic compounds (factor x a? inhibitors 14) |
| 07/02/2003 | EP1322617A1 Compounds and methods for modulation of estrogen receptors |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | CN1427721A Peptide deformylase inhibitors |
| 07/01/2003 | US6586597 Reduction of N-tert-butyl-1,2,3,4-tetrahydro-3(S)-isoquinolinecarboxamide using hydrogenation catalyst on supports to form intermediates for antagonists of excitatory amino acid receptors or enzyme inhibitors; viral diseases |
| 06/26/2003 | WO2003051882A1 A2a adenosine receptor antagonists |
| 06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | US20030120072 Such as (4-(3,4-Difluoro-phenyl)-piperazin-1-yl)-((4S ,4aS,8aR)-2-((S)-3-(6-methoxy-pyridin-3-yl)-2-methyl-propyl)-decahydro -isoquinolin-4yl)-methanone for treatment of schizophrenia, depression, anxiety and bipolar disorders |
| 06/26/2003 | US20030119876 Compounds for the treatment of protozoal diseases |
| 06/26/2003 | US20030119858 Conformationally constrained compounds as pharmaceutical agents |
| 06/26/2003 | US20030119854 Compounds and methods for modulating CXCR3 function |
| 06/26/2003 | US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 06/26/2003 | US20030119729 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease |
| 06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |